Management of acute ischemic stroke. What is the role of tPA and antithrombotic agents?

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Every patient with acute stroke who presents to a medical center that has appropriate resources should undergo evaluation for intravenous tPA therapy. Such therapy should not be given unless the patient meets strict eligibility criteria based on clinical, radiographic, and laboratory data. Intra-arterial thrombolysis may be a promising alternative to intravenous tPA therapy, but it should still be regarded as experimental. Daily aspirin therapy should be initiated immediately in most patients who do not receive intravenous tPA therapy and after 24 hours in most patients who receive this treatment. Measures should be taken to prevent medical complications, such as aspiration pneumonia, deep vein thrombosis, contractures, and pressure sores. Early initiation of rehabilitation can maximize stroke recovery. Whenever feasible, institutions should have stroke teams or units to streamline care and provide expertise for patients with acute stroke.

Original languageEnglish (US)
Pages (from-to)85-86+89
JournalPostgraduate Medicine
Volume107
Issue number6
StatePublished - May 15 2000

Fingerprint

Fibrinolytic Agents
Stroke
Therapeutics
Aspiration Pneumonia
Pressure Ulcer
Contracture
Venous Thrombosis
Aspirin
Rehabilitation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Management of acute ischemic stroke. What is the role of tPA and antithrombotic agents? / Meschia, James F.

In: Postgraduate Medicine, Vol. 107, No. 6, 15.05.2000, p. 85-86+89.

Research output: Contribution to journalArticle

@article{46b002cbdf5949ba9198985da9187e89,
title = "Management of acute ischemic stroke. What is the role of tPA and antithrombotic agents?",
abstract = "Every patient with acute stroke who presents to a medical center that has appropriate resources should undergo evaluation for intravenous tPA therapy. Such therapy should not be given unless the patient meets strict eligibility criteria based on clinical, radiographic, and laboratory data. Intra-arterial thrombolysis may be a promising alternative to intravenous tPA therapy, but it should still be regarded as experimental. Daily aspirin therapy should be initiated immediately in most patients who do not receive intravenous tPA therapy and after 24 hours in most patients who receive this treatment. Measures should be taken to prevent medical complications, such as aspiration pneumonia, deep vein thrombosis, contractures, and pressure sores. Early initiation of rehabilitation can maximize stroke recovery. Whenever feasible, institutions should have stroke teams or units to streamline care and provide expertise for patients with acute stroke.",
author = "Meschia, {James F}",
year = "2000",
month = "5",
day = "15",
language = "English (US)",
volume = "107",
pages = "85--86+89",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "6",

}

TY - JOUR

T1 - Management of acute ischemic stroke. What is the role of tPA and antithrombotic agents?

AU - Meschia, James F

PY - 2000/5/15

Y1 - 2000/5/15

N2 - Every patient with acute stroke who presents to a medical center that has appropriate resources should undergo evaluation for intravenous tPA therapy. Such therapy should not be given unless the patient meets strict eligibility criteria based on clinical, radiographic, and laboratory data. Intra-arterial thrombolysis may be a promising alternative to intravenous tPA therapy, but it should still be regarded as experimental. Daily aspirin therapy should be initiated immediately in most patients who do not receive intravenous tPA therapy and after 24 hours in most patients who receive this treatment. Measures should be taken to prevent medical complications, such as aspiration pneumonia, deep vein thrombosis, contractures, and pressure sores. Early initiation of rehabilitation can maximize stroke recovery. Whenever feasible, institutions should have stroke teams or units to streamline care and provide expertise for patients with acute stroke.

AB - Every patient with acute stroke who presents to a medical center that has appropriate resources should undergo evaluation for intravenous tPA therapy. Such therapy should not be given unless the patient meets strict eligibility criteria based on clinical, radiographic, and laboratory data. Intra-arterial thrombolysis may be a promising alternative to intravenous tPA therapy, but it should still be regarded as experimental. Daily aspirin therapy should be initiated immediately in most patients who do not receive intravenous tPA therapy and after 24 hours in most patients who receive this treatment. Measures should be taken to prevent medical complications, such as aspiration pneumonia, deep vein thrombosis, contractures, and pressure sores. Early initiation of rehabilitation can maximize stroke recovery. Whenever feasible, institutions should have stroke teams or units to streamline care and provide expertise for patients with acute stroke.

UR - http://www.scopus.com/inward/record.url?scp=0343962196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343962196&partnerID=8YFLogxK

M3 - Article

VL - 107

SP - 85-86+89

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 6

ER -